557 related articles for article (PubMed ID: 15013721)
1. COX-2: a target for prevention and treatment of esophageal cancer.
Altorki N
J Surg Res; 2004 Mar; 117(1):114-20. PubMed ID: 15013721
[No Abstract] [Full Text] [Related]
2. [Colorectal cancer and inhibition of cyclooxygenase-2].
Geissler M; Mohr L; Blum HE
Dtsch Med Wochenschr; 2002 Jun; 127(23):1256-8. PubMed ID: 12053285
[No Abstract] [Full Text] [Related]
3. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
Gupta RA; Dubois RN
Nat Rev Cancer; 2001 Oct; 1(1):11-21. PubMed ID: 11900248
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review.
Pruthi RS; Derksen E; Gaston K
J Urol; 2003 Jun; 169(6):2352-9. PubMed ID: 12771797
[TBL] [Abstract][Full Text] [Related]
5. COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancer.
Saha D; Pyo H; Choy H
Am J Clin Oncol; 2003 Aug; 26(4):S70-4. PubMed ID: 12902860
[TBL] [Abstract][Full Text] [Related]
6. Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer.
Liao Z; Milas L; Komaki R; Stevens C; Cox JD
Am J Clin Oncol; 2003 Aug; 26(4):S85-91. PubMed ID: 12902863
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 inhibitor therapy for the prevention of esophageal adenocarcinoma in Barrett's esophagus.
Gupta RA; DuBois RN
J Natl Cancer Inst; 2002 Mar; 94(6):406-7. PubMed ID: 11904306
[No Abstract] [Full Text] [Related]
8. [COX-2 expression in gastric cancers].
Sakamoto C
Nihon Rinsho; 2001 Apr; 59 Suppl 4():598-603. PubMed ID: 11424449
[No Abstract] [Full Text] [Related]
9. The discovery and function of COX-2.
Needleman P; Isakson PC
J Rheumatol Suppl; 1997 Jul; 49():6-8. PubMed ID: 9249644
[No Abstract] [Full Text] [Related]
10. Researchers plan to continue to study COX-2 inhibitors in cancer treatment and prevention.
Vanchieri C
J Natl Cancer Inst; 2005 Apr; 97(8):552-3. PubMed ID: 15840872
[No Abstract] [Full Text] [Related]
11. COX-1 and COX-2 inhibition: current status and future perspective.
Greyn J; Lauwers MH; Vanlersberghe C; Camu F
Acta Anaesthesiol Belg; 1998; 49(3):175-83. PubMed ID: 9844704
[No Abstract] [Full Text] [Related]
12. [Cyclo-oxygenase 2 inhibitors and cancer].
André T; Soria JC
Bull Cancer; 2004 May; 91 Spec No():S59-60. PubMed ID: 15239332
[No Abstract] [Full Text] [Related]
13. [Physiopathological and therapeutic study of collagen diseases based on results of clinical tests--role of prostaglandins].
Sano H
Nihon Naika Gakkai Zasshi; 1998 Dec; 87(12):2438-45. PubMed ID: 9922664
[No Abstract] [Full Text] [Related]
14. Cyclooxygenase-2 (COX-2) enzyme inhibitors and radiotherapy: preclinical basis.
Milas L
Am J Clin Oncol; 2003 Aug; 26(4):S66-9. PubMed ID: 12902859
[TBL] [Abstract][Full Text] [Related]
15. Piroxicam is an ineffective inhibitor of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus.
Carlton PS; Gopalakrishnan R; Gupta A; Liston BW; Habib S; Morse MA; Stoner GD
Cancer Res; 2002 Aug; 62(15):4376-82. PubMed ID: 12154043
[TBL] [Abstract][Full Text] [Related]
16. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
[TBL] [Abstract][Full Text] [Related]
17. COX-2 inhibition: not too hot, not too cold--(perhaps) just right?
Bakowsky V; Hanly JG
J Rheumatol; 2000 Dec; 27(12):2734-7. PubMed ID: 11128655
[No Abstract] [Full Text] [Related]
18. Role of cyclooxygenase-2 in the development and treatment of oesophageal adenocarcinoma.
Buskens CJ; Ristimäki A; Offerhaus GJ; Richel DJ; van Lanschot JJ
Scand J Gastroenterol Suppl; 2003; (239):87-93. PubMed ID: 14743889
[TBL] [Abstract][Full Text] [Related]
19. [COX-1 and COX-2: functions and pharmacological effects].
Hinz B; Brune K
Pharm Unserer Zeit; 1999 Jan; 28(1):21-9. PubMed ID: 10078026
[No Abstract] [Full Text] [Related]
20. [Cyclooxygenases in the spinal cord and the relationship with pain].
Li SQ; Li WB
Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):359-60. PubMed ID: 14992024
[No Abstract] [Full Text] [Related]
[Next] [New Search]
